• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA FOXP4-AS1在人类癌症中的新作用:从分子生物学到临床应用

Emerging roles of long non-coding RNA FOXP4-AS1 in human cancers: From molecular biology to clinical application.

作者信息

Yang Jingjie

机构信息

Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, 443002, China.

College of Basic Medical Science, China Three Gorges University, Yichang, 443002, China.

出版信息

Heliyon. 2024 Oct 26;10(21):e39857. doi: 10.1016/j.heliyon.2024.e39857. eCollection 2024 Nov 15.

DOI:10.1016/j.heliyon.2024.e39857
PMID:39539976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11558633/
Abstract

Forkhead box P4 antisense RNA 1 (FOXP4-AS1) is a long non-coding RNA (lncRNA) situated on the human chromosome 6p21.1 locus. Previous research has demonstrated that FOXP4-AS1 is dysregulated in various cancers and exhibits a dual purpose as a tumor suppressor or oncogene in specific types of cancer. The levels of FOXP4-AS1 are significantly correlated with clinical features of cancer as well as prognosis. Additionally, FOXP4-AS1 is stimulated by transcription factors ATF3, YY1, PAX5, and SP4. The molecular mechanisms of FOXP4-AS1 in cancer are quite complex. It competitively sponges multiple miRNAs, bidirectionally regulates the levels of host gene FOXP4, activates the PI3K/AKT, Wnt/β-catenin, and ERK/MAPK signaling pathways, and recruits chromatin-modifying enzymes or interacts with other proteins to regulate malignant phenotypes of tumors, including proliferation, invasion, epithelial-mesenchymal transition (EMT), and angiogenesis. In this review, we provide an overview of the latest developments in FOXP4-AS1 oncology research, outlines its molecular regulatory networks in cancer, and discusses its prospective relevance as a cancer therapeutic target as well as a biomarker for prognosis and diagnosis.

摘要

叉头框P4反义RNA 1(FOXP4-AS1)是一种长链非编码RNA(lncRNA),位于人类染色体6p21.1位点。先前的研究表明,FOXP4-AS1在多种癌症中表达失调,并且在特定类型的癌症中具有作为肿瘤抑制因子或癌基因的双重作用。FOXP4-AS1的水平与癌症的临床特征以及预后显著相关。此外,FOXP4-AS1受转录因子ATF3、YY1、PAX5和SP4的刺激。FOXP4-AS1在癌症中的分子机制相当复杂。它竞争性地吸附多种微小RNA(miRNA),双向调节宿主基因FOXP4的水平,激活PI3K/AKT、Wnt/β-连环蛋白和ERK/MAPK信号通路,并招募染色质修饰酶或与其他蛋白质相互作用以调节肿瘤的恶性表型,包括增殖、侵袭、上皮-间质转化(EMT)和血管生成。在本综述中,我们概述了FOXP4-AS1肿瘤学研究的最新进展,勾勒了其在癌症中的分子调控网络,并讨论了其作为癌症治疗靶点以及预后和诊断生物标志物的潜在相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9383/11558633/51d911959906/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9383/11558633/60062e97cac5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9383/11558633/805d8600543b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9383/11558633/cb8712343156/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9383/11558633/51d911959906/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9383/11558633/60062e97cac5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9383/11558633/805d8600543b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9383/11558633/cb8712343156/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9383/11558633/51d911959906/gr4.jpg

相似文献

1
Emerging roles of long non-coding RNA FOXP4-AS1 in human cancers: From molecular biology to clinical application.长链非编码RNA FOXP4-AS1在人类癌症中的新作用:从分子生物学到临床应用
Heliyon. 2024 Oct 26;10(21):e39857. doi: 10.1016/j.heliyon.2024.e39857. eCollection 2024 Nov 15.
2
Participation of Long Noncoding RNA FOXP4-AS1 in the Development and Progression of Endometrioid Carcinoma with Epigenetically Silencing .长链非编码 RNA FOXP4-AS1 通过表观遗传沉默参与子宫内膜样癌的发生发展
Cancer Biother Radiopharm. 2024 Aug;39(6):451-462. doi: 10.1089/cbr.2023.0039. Epub 2024 Mar 20.
3
Activating transcription factor 3-activated long noncoding RNA forkhead box P4-antisense RNA 1 aggravates colorectal cancer progression by regulating microRNA-423-5p/nucleus accumbens associated 1 axis.激活转录因子 3 激活的长非编码 RNA 叉头框 P4 反义 RNA 1 通过调节 microRNA-423-5p/伏隔核相关 1 轴加重结直肠癌进展。
Bioengineered. 2022 Feb;13(2):2114-2129. doi: 10.1080/21655979.2021.2023798.
4
The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets.lncRNA FOXP4-AS1 在癌症患者中的临床预后价值:基于 TCGA 数据集的荟萃分析和生物信息学分析。
Medicine (Baltimore). 2022 Oct 21;101(42):e31439. doi: 10.1097/MD.0000000000031439.
5
Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.鉴定长链非编码 RNA 叉头框蛋白 P4 反义 RNA 1 在早期胰腺导管腺癌患者中的潜在临床意义。
Cancer Med. 2020 Mar;9(6):2062-2076. doi: 10.1002/cam4.2818. Epub 2020 Jan 28.
6
LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4.长链非编码 RNA FOXP4-AS1 受 PAX5 激活,并通过与 miR-3184-5p 结合来上调 FOXP4,从而促进前列腺癌的生长。
Cell Death Dis. 2019 Jun 17;10(7):472. doi: 10.1038/s41419-019-1699-6.
7
FOXP4-AS1 Inhibits Papillary Thyroid Carcinoma Proliferation and Migration Through the AKT Signaling Pathway.FOXP4-AS1通过AKT信号通路抑制甲状腺乳头状癌的增殖和迁移。
Front Oncol. 2022 Jun 2;12:900836. doi: 10.3389/fonc.2022.900836. eCollection 2022.
8
YY1-induced upregulation of FOXP4-AS1 and FOXP4 promote the proliferation of esophageal squamous cell carcinoma cells.YY1 诱导的 FOXP4-AS1 和 FOXP4 的上调促进食管鳞状细胞癌细胞的增殖。
Cell Biol Int. 2020 Jul;44(7):1447-1457. doi: 10.1002/cbin.11338. Epub 2020 Apr 20.
9
LncRNA FOXP4-AS1 Is Involved in Cervical Cancer Progression via Regulating miR-136-5p/CBX4 Axis.长链非编码RNA FOXP4-AS1通过调控miR-136-5p/CBX4轴参与宫颈癌进展。
Onco Targets Ther. 2020 Mar 19;13:2347-2355. doi: 10.2147/OTT.S241818. eCollection 2020.
10
LncRNA FOXP4-AS1 silencing inhibits metastasis and epithelial-mesenchymal transition in nasopharyngeal carcinoma via miR-136-5p/MAPK1.长链非编码RNA FOXP4-AS1沉默通过miR-136-5p/MAPK1抑制鼻咽癌的转移和上皮-间质转化。
Anticancer Drugs. 2023 Nov 1;34(10):1104-1111. doi: 10.1097/CAD.0000000000001510. Epub 2023 Mar 24.

引用本文的文献

1
The Good, the Bad, or Both? Unveiling the Molecular Functions of LINC01133 in Tumors.是好、是坏,还是兼而有之?揭示LINC01133在肿瘤中的分子功能。
Noncoding RNA. 2025 Jul 30;11(4):58. doi: 10.3390/ncrna11040058.
2
Clinical significance and biological function of PRKCQ-AS1/miR-582-3p expression in LUAD.PRKCQ-AS1/miR-582-3p表达在肺腺癌中的临床意义及生物学功能
Hereditas. 2025 Jul 1;162(1):116. doi: 10.1186/s41065-025-00482-9.

本文引用的文献

1
Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection.子宫内膜癌的分子分类及其对治疗选择的影响。
Int J Mol Sci. 2024 May 28;25(11):5893. doi: 10.3390/ijms25115893.
2
Circulating non-coding RNA biomarkers of endocrine tumours.循环非编码 RNA 标志物在内分泌肿瘤中的应用。
Nat Rev Endocrinol. 2024 Oct;20(10):600-614. doi: 10.1038/s41574-024-01005-8. Epub 2024 Jun 17.
3
Osteosarcoma in a ceRNET perspective.中枢神经系统外尤文肉瘤的临床特征。
J Biomed Sci. 2024 Jun 5;31(1):59. doi: 10.1186/s12929-024-01049-y.
4
FOXP4-mediated induction of PTK7 activates the Wnt/β-catenin pathway and promotes ovarian cancer development.FOXP4 介导的 PTK7 诱导激活 Wnt/β-连环蛋白通路并促进卵巢癌发展。
Cell Death Dis. 2024 May 13;15(5):332. doi: 10.1038/s41419-024-06713-7.
5
Neoadjuvant management of locally advanced pancreatic ductal adenocarcinoma - Heading towards a promising change in treatment paradigm.局部进展期胰导管腺癌的新辅助治疗-治疗模式的潜在改变。
Cancer Treat Rev. 2024 Jun;127:102750. doi: 10.1016/j.ctrv.2024.102750. Epub 2024 May 3.
6
FOXP4-AS1 promotes CD8 T cell exhaustion and esophageal cancer immune escape through USP10-stabilized PD-L1.FOXP4-AS1 通过 USP10 稳定的 PD-L1 促进 CD8 T 细胞耗竭和食管癌免疫逃逸。
Immunol Res. 2024 Aug;72(4):766-775. doi: 10.1007/s12026-024-09482-9. Epub 2024 Apr 30.
7
CD8 T cell-based cancer immunotherapy.基于 CD8 T 细胞的癌症免疫疗法。
J Transl Med. 2024 Apr 29;22(1):394. doi: 10.1186/s12967-024-05134-6.
8
LncRNA DLG5-AS1 facilitates breast cancer cell proliferation and invasion by promoting EZH2-mediated transcriptional silencing of SFRP1.长链非编码 RNA DLG5-AS1 通过促进 EZH2 介导的 SFRP1 转录沉默促进乳腺癌细胞增殖和侵袭。
Arch Biochem Biophys. 2024 Jun;756:110018. doi: 10.1016/j.abb.2024.110018. Epub 2024 Apr 26.
9
Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review.非编码 RNA 靶向治疗:最新综述。
Int J Mol Sci. 2024 Mar 24;25(7):3630. doi: 10.3390/ijms25073630.
10
Promising predictive molecular biomarkers for cervical cancer (Review).有前途的宫颈癌预测性分子生物标志物(综述)。
Int J Mol Med. 2024 Jun;53(6). doi: 10.3892/ijmm.2024.5374. Epub 2024 Apr 12.